U.S. Healthtech Stock News

Astec Industries (ASTE) just reported first quarter 2026 results that combined strong revenue and backlog with weaker profit margins, as cost inflation, product mix, and higher tariffs and trade show spending reduced earnings. See our latest analysis for Astec Industries. Astec Industries' 1 day share price return of 0.64% comes after the Q1 miss on profit. The 7 day and 30 day share price returns are down 13.34% and 12.87%. By contrast, the year to date share price return of 19.52% and 1...

ETF launch puts Northern Trust’s expertise in focus Northern Trust (NTRS) recently supported the launch of the first autocallable ETF in Europe on the Waystone ETF ICAV platform, an event that draws attention to its role in complex asset servicing. The new Calamos Autocallable Income UCITS fund uses a derivatives based, synthetic approach that aims to mirror a benchmark tracking a diversified basket of synthetic autocallable notes. For you as an investor, this highlights Northern Trust’s...

Wondering whether EyePoint at US$13.66 still offers value after a big run, or whether most of the opportunity is already priced in. The stock is up 133.5% over the past year and 127.7% over three years, even though it has fallen 1.4% over the last week, 3.7% over the past month and 21.9% year to date. Recent market attention on EyePoint has focused on its position within the US pharmaceuticals and biotech space and how investors are reassessing risk across smaller healthcare stocks...

Uranium Energy Corp. has recently received regulatory approval and begun production at its Burke Hollow in‑situ recovery uranium mine, while also commissioning additional header houses at its Christensen Ranch operation to expand wellfield capacity. This marks the first new U.S. in‑situ recovery uranium mine in more than a decade, underlining Uranium Energy’s push to scale domestic uranium supply and broaden its operational footprint across key producing hubs. We’ll now examine how the...

If you are wondering whether Broadcom at around US$430 a share still offers value, the key question is how that price compares with what the business may be worth. The stock has posted returns of 3.2% over the last week, 15.7% over the last month, 23.7% year to date and 95.6% over the past year, which naturally raises questions about growth expectations and risk. Recent coverage has focused on Broadcom's role in semiconductors and related technology, with attention on how the company fits...

In late April 2026, Costamare Inc. reported first quarter 2026 results showing revenue of US$211.06 million and net income of US$80.4 million, while also indicating it would propose raising its quarterly dividend from US$0.115 to US$0.125 per common share beginning in the second quarter of 2026. This combination of lower year‑on‑year earnings and a planned dividend increase gives investors fresh insight into how management is balancing current profitability with cash returns to...

GE Vernova (NYSE:GEV) has selected Scotland’s Maraen Port of Nigg as the marshalling hub for turbine components for the Dogger Bank Wind Farm phases B and C. The port will handle logistics and staging activity for upcoming project phases, supporting one of the world's largest offshore wind developments. This appointment adds another large offshore wind project to GE Vernova’s execution pipeline in the European renewables supply chain. For investors following NYSE:GEV, this move underlines...

Encore Capital Group has recently announced a private offering of US$550 million senior secured notes due 2032 to institutional investors, with the proceeds earmarked to redeem existing US$500 million 9.250% senior secured notes due 2029 and EUR 200 million of its EUR 415 million floating rate notes due 2028, while covering related premiums, interest, and transaction costs. Alongside this refinancing move, Encore reported strong first quarter 2026 results with higher revenue, net income, and...

In the past quarter, East West Bancorp reported a 23% rise in net income to US$358 million for Q1 2026, supported by higher net interest income, loan growth to US$58.10 billion, deposit growth to US$68.90 billion, and a lower provision for credit losses. An increase in unrealized losses on available-for-sale securities and cash flow hedges widened accumulated other comprehensive loss to US$388.20 million, slightly reducing total stockholders’ equity even as core operations strengthened. We...

Delta Air Lines has warned that an ongoing US International Trade Commission probe could disrupt its partnership with Joby Aviation (NYSE:JOBY). The investigation is tied to patent infringement allegations brought by competitor Archer Aviation. Delta indicated that an adverse outcome could potentially restrict or remove Joby eVTOL aircraft from the US market. Joby Aviation, which is developing electric vertical take off and landing aircraft for short distance passenger flights, has been a...

Hawaiian Electric Industries (HE) is back in focus after finalizing the global Maui wildfire settlement and making the first of four annual payments, alongside first quarter earnings and a credit rating upgrade from Moody's. See our latest analysis for Hawaiian Electric Industries. There has been a sharp reset in sentiment, with the share price down 11.2% over the past 90 days but still up 17.4% year to date. The 1 year total shareholder return of 38.7% contrasts with a much weaker 3 and 5...

Why the latest earnings matter for Syndax Pharmaceuticals (SNDX) Syndax Pharmaceuticals (SNDX) reported first quarter 2026 revenue of US$64.86 million compared with US$20.04 million a year earlier, with net loss narrowing to US$42.67 million and loss per share at US$0.48, down from US$0.98. See our latest analysis for Syndax Pharmaceuticals. Alongside the stronger quarterly figures, Syndax Pharmaceuticals’ recent price action has been mixed, with a 7 day share price return of 7.67% and a 30...

Astrana Health stock performance snapshot Astrana Health (ASTH) has drawn investor attention after a strong recent run, with the stock up 8.9% in the past day, 12.3% over the week, and 42.2% over the past month. See our latest analysis for Astrana Health. Those short term share price moves sit on top of a much stronger run, with a 90 day share price return of 103.9% and a 1 year total shareholder return of 37.7%. This points to building momentum as investors reassess Astrana Health's growth...

Why Quantum Computing stock is back on investors’ radar Quantum Computing (QUBT) has moved back into focus after a sharp month move of 36%, prompting investors to reassess how its photonics based quantum and AI hardware story fits into their portfolios. See our latest analysis for Quantum Computing. At a share price of $9.60, Quantum Computing’s recent 36% 30 day share price return stands in contrast to its year to date share price decline of 12.8%, while the 3 year total shareholder return...

BioMarin Pharmaceutical (BMRN) is back in focus after raising its full year 2026 revenue outlook to US$3.83b to US$3.93b and releasing fresh VOXZOGO clinical data in children with achondroplasia. See our latest analysis for BioMarin Pharmaceutical. Despite the raised 2026 revenue guidance and encouraging VOXZOGO data, BioMarin Pharmaceutical’s share price has drifted, with the 90 day share price return down 9.39% and the 3 year total shareholder return down 43.20%, pointing to fading...

Broadridge Financial Solutions (NYSE:BR) added Goldman Sachs, J.P. Morgan, TD Securities, Morgan Stanley, and Bank of America as fully integrated liquidity providers on its LTX bond trading platform. J.P. Morgan and TD Securities joined the LTX board as part of the expansion, deepening their involvement with the AI powered electronic bond trading venue. The new relationships increase the institutional presence on LTX and broaden its reach across the corporate bond market. For you as an...

Installed Building Products, Inc. reported first-quarter 2026 results with sales of US$660.5 million and net income of US$34.8 million, while also appointing Ryan Ricketts as Director of Investor Relations and Financial Planning and declaring a US$0.39 per-share quarterly dividend payable on June 30, 2026. The quarter highlighted pressure on residential installation volumes alongside growth in commercial and manufacturing segments and a higher dividend, underscoring a shift in the company’s...

In the first quarter of 2026, Palantir Technologies reported revenue of US$1,632.58 million and net income of US$870.53 million, sharply higher than a year earlier, and raised its 2026 revenue outlook to between US$7.65 billion and US$7.66 billion while guiding to continued GAAP profitability. A new three-year partnership with Cleveland-Cliffs to embed Palantir’s AI platform directly into core manufacturing and commercial workflows underscores how operational AI deployments are increasingly...

In recent months, FuelCell Energy reported a fiscal first-quarter loss per share that improved by 61% year over year and introduced standardized 12.5 MW fuel cell power blocks aimed at faster deployment in grid-constrained, AI-driven data center markets, while also outlining plans to expand manufacturing capacity. At the same time, insider ownership changes, a strong cash position with low debt, and a growing proposal pipeline for data center projects have sharpened investor attention on how...

If you are wondering whether Amylyx Pharmaceuticals at US$14.73 is still offering value after a strong run, it helps to step back and look at what the price is really reflecting. The stock is up 29.0% year to date and 220.2% over the past year, even though it has fallen about 10.5% over the past week and 10.0% over the past month. These moves can change how you think about both opportunity and risk. Across financial media and industry commentary, recent attention has focused on Amylyx as a...

Wondering if Titan America at US$16.52 is offering genuine value or just headline noise? This article walks through what the current price might be telling you about the stock. The share price has returned 2.9% over the past week and 2.5% over the past month, while the year to date performance is a decline of 1.1% and the 1 year return sits at 16.7%. Recent news coverage has focused on Titan America as part of broader interest in Basic Materials stocks and renewed attention on valuation...

Recent share performance and business profile KLA (KLAC) has drawn investor attention on recent share performance, with gains over the past week, month and past 3 months, alongside a 1-year total return that is a multiple of the starting value. The company focuses on process control, inspection and metrology solutions for semiconductor manufacturers and related electronics markets worldwide, spanning wafer inspection tools, metrology systems and software aimed at supporting yield management...

As you might know, Harmony Biosciences Holdings, Inc. ( NASDAQ:HRMY ) last week released its latest first-quarter, and...

Janux Therapeutics, Inc. ( NASDAQ:JANX ) came out with its quarterly results last week, and we wanted to see how the...